Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Celgene    CELG   

CELGENE

(CELG)
SummaryQuotesChartsNewsCompanyFinancials 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Health Care Flat Amid Mixed Earnings -- Health Care Roundup

share with twitter share with LinkedIn share with facebook
share via e-mail
02/06/2020 | 05:05pm EDT

Health-care companies were flat as investors digested a mixed earnings season.

Bristol-Myers Squibb shares rose after it said the recent acquisition of Celgene boosted its fourth-quarter revenue, even as higher expenses triggered a loss for the quarter.

The whistleblowing Chinese doctor, Li Wenliang, who was among the first to flag the existence of a dangerous coronavirus now spreading around the world, died on Friday morning, according to the hospital where he was being treated after becoming infected by the pathogen.

Write to Rob Curran at rob.curran@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CELGENE
02/06Health Care Flat Amid Mixed Earnings -- Health Care Roundup
DJ
02/06BRISTOL MYERS SQUIBB : Swings to 4Q Loss, Beats Sales Expectations
DJ
02/06BRISTOL MYERS SQUIBB : Sets 2020 Outlook
DJ
01/13NEWS HIGHLIGHTS : Top Company News of the Day
DJ
01/13NEWS HIGHLIGHTS : Top Company News of the Day
DJ
01/13NEWS HIGHLIGHTS : Top Company News of the Day
DJ
01/13NEWS HIGHLIGHTS : Top Company News of the Day
DJ
01/13NEWS HIGHLIGHTS : Top Company News of the Day
DJ
01/13WHAT'S NEWS : Business & Finance -- WSJ
DJ
01/13Bristol-Myers Deal Starts to Pay Off as Treatments Advance -- WSJ
DJ
More news
Chart CELGENE
Duration : Period :
Celgene Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers
NameTitle
Matt M. Roden President & Director
David V. Elkins CFO, Principal Accounting Officer & Executive VP
Aijaz Tobaccowalla Chief Digital & Information Officer, Senior VP
Robert M. Plenge VP-R&D, Head-Inflammation & Immunology
P. Joseph Campisi Director & Vice President